Back to Journals » OncoTargets and Therapy » Volume 7

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Total article views   HTML views PDF downloads Totals
13,317 Dovepress* 10,087+ 3,309 13,396
PubMed Central* 3,230 1,110 4,340
Totals 13,317 4,419 17,736
*Since 5 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar